Decision on introduction of ACPi product to Iran, and application for KFDA | |
---|---|
Decision on introduction of ACPi product,
Iran, consultation on MOH (Iran Food and Drug Administration) registration
procedure, and ACPi manual, application for domestic Food and Drug
Administration certification P Company, an Iranian partner who decided
to introduce CSTD for anticancer drug preparation, decided to introduce ACPi
with ACPi and AACPi technology competitiveness, and has requested CE, PMDA
(Japanese certification), and FDA certification. Manual is the same as the Anyfusion pump,
and responds to the domestic and CE certification status so that it can be
exported quickly. This contract is intended to be concluded
after domestic certification. Many hospitals where ACPi has been
introduced in Korea are also considering the purchase of manual ACPI due to the
difficulty of the anticancer drug preparation environment. We would like to request a sufficient
performance test to the company and an authorized institution before
permission. Medical institutions in Seoul and the
metropolitan area are requesting reliable performance test data from accredited
institutions, and these data will be helpful for the sales of ACPi. Thank you. |
Next | Decision to register two patents for ACPi and second cylinder pump |
---|---|
Prev | Concluded consulting CDA for entering the Japanese market with two Japanese companies |